|
RIC8A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.779500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.373770E-01 |
| Normal-vs-Stage2 |
7.093600E-01 |
| Normal-vs-Stage3 |
2.957500E-02 |
| Normal-vs-Stage4 |
9.362200E-01 |
| Stage1-vs-Stage2 |
4.502400E-01 |
| Stage1-vs-Stage3 |
2.105800E-01 |
| Stage1-vs-Stage4 |
4.961400E-01 |
| Stage2-vs-Stage3 |
1.153210E-01 |
| Stage2-vs-Stage4 |
7.628000E-01 |
| Stage3-vs-Stage4 |
1.625630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.455900E-02 |
| Normal-vs-AfricanAmerican |
9.394200E-02 |
| Normal-vs-Asian |
7.085400E-01 |
| Caucasian-vs-AfricanAmerican |
9.141800E-01 |
| Caucasian-vs-Asian |
9.569400E-01 |
| AfricanAmerican-vs-Asian |
9.214200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.475420E-01 |
| Normal-vs-Female |
2.262700E-03 |
| Male-vs-Female |
1.587760E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.818000E-01 |
| Normal-vs-Extreme_Weight |
1.744230E-01 |
| Normal-vs-Obese |
5.083900E-02 |
| Normal-vs-Extreme_Obese |
3.130600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.914400E-01 |
| Normal_Weight-vs-Obese |
5.316200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.179600E-01 |
| Extreme_Weight-vs-Obese |
4.597400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.847360E-01 |
| Obese-vs-Extreme_Obese |
1.096840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.231800E-04 |
| Normal-vs-Age(41-60Yrs) |
6.542500E-03 |
| Normal-vs-Age(61-80Yrs) |
5.126800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.550400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.239830E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.419100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.077830E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.943640E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.289400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.158800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.035900E-03 |
| Normal-VS-Type2 PRCC |
8.838600E-01 |
| Normal-VS-KIRP CIMP |
1.092760E-01 |
| Normal-VS-Unclassified PRCC |
3.751600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.088300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.146000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.711600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.487600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.390400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.771200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.053200E-01 |
| Normal-vs-N1 |
2.964000E-01 |
| Normal-vs-N2 |
9.568400E-01 |
| N0-vs-N1 |
5.767000E-01 |
| N0-vs-N2 |
8.823800E-01 |
| N1-vs-N2 |
7.187800E-01 |
|
|
